Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TYRSI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-CD19 monoclonal antibody-liposomal sodium butyrate conjugate
|
|||||
| Synonyms |
J3119liposomal sodium butyrate conjugate
Click to Show/Hide
|
|||||
| Organization |
Seattle Biomembrane Institute
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Lymphoma [ICD11:2A85-2A90]
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-lymphocyte antigen CD19 (CD19)
|
Antigen Info | ||||
| Payload Name |
Sodium butyrate
|
Payload Info | ||||
| Therapeutic Target |
Histone deacetylase 1 (HDAC1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.